Despite improvements to intensive care management and specifi c pharmacological treatments (atropine, oxime, diazepam), the mortality associated with organophosphate (OP) poisoning has not substantially decreased. The objective of this examination was to describe the role of fresh frozen plasma (FFP) in acute OP poisoning. After a deliberate ingestion of malathion, a 55-year-old male suffering from miosis, somnolence, bradycardia, muscular fasciculations, rales on auscultation, respiratory insuffi ciency, as well as from an inhibition of red blood cell acetylcholinesterase (AChE) and plasma butyrylcholinesterase (BuChE), was admitted to hospital. Malathion was confi rmed in a concentration of 18.01 mg L -1 . Apart from supportive measures (including mechanical ventilation for four days), antidotal treatment with atropine, oxime -pralidoxime methylsulphate (Contrathion ® ), and diazepam was administered, along with FFP. The potentially benefi cial effects of FFP therapy included a prompt increase of BuChE activity (from 926 IU L -1 to 3277 IU L -1 ; reference range from 7000 IU L -1 to 19000 IU L -1 ) and a reduction in the malathion concentration, followed by clinical recovery. Due to BuChE replacement, albumin content, and volume restitution, FFP treatment may be used as an alternative approach in patients with acute OP poisoning, especially when oximes are not available.
The conventional approach to organophosphate (OP) poisoning treatment involves efforts to counteract the effects of excessive acetylcholine (ACh) accumulation and the overstimulation of cholinergic neurons caused by irreversible acetylcholinesterase (AChE) inhibition. Atropine effectively reduces muscarinic signs, while oximes reactivate inhibited AChE and directly detoxify unbound OPs (1) . Despite the use of these antidotes and improvements to intensive care, the mortality associated with OP poisoning remains high and calls for new alternative treatments (2, 3) . Fresh frozen plasma (FFP) or albumin, acting as a bioscavenger to clean up circulatory OPs, has been evaluated as an alternative treatment modality, but the few studies that have investigated it are controversial and need to be clarifi ed (4, 5) .
SUBJECTS AND METHODS
A 55-year-old farmer was brought to the National Poison Control Centre with miosis and an organic solvent-like odour. The patient complained of nausea, vomiting, and diarrhoea, but his vital signs were normal: blood pressure 140 mm Hg /70 mm Hg, pulse 70 bpm, oxygen saturation (sO 2 ) 96 %. Three hours earlier, he drank 100 mL of pesticide formula, containing 600 g L -1 of malathion. A gastric lavage was performed, followed by an administration of 50 g of activated charcoal and an evacuation of white coloured solution. After admission to the Intensive Care Unit 4 h after ingestion, he was somnolent, spontaneously breathing, with copious bronchial secretion, pinpoint pupils, muscle fasciculations, hypotension (90 mm Hg /70 mm Hg), pulse 90 bpm, and had a respiratory rate of 25 min -1 . Apart from supportive measures, he received 12 mg of atropine during the fi rst 30 min, followed by a continuous infusion of atropine. The patient was administered 2 g of pralidoxime methylsulphate as a loading dose, followed by 500 mg h -1 in a continuous infusion and fresh frozen plasma (two bags, from 220 mL to 250 mL every 12 h for 2 days; total of 8 bags , the level increased to 1576 U L -1 after the fi rst, and from 3227 IU L -1 to 5816 IU L -1 after the second dose) (Figure 1 ). In order to evaluate the capacity of FFP for binding malathion to albumin (mean value 4.1 g L -1 ), a water solution of insecticide was incubated in vitro with FFP in a molar ratio 1:1 of its albumin content. The mixture was kept in a water bath at 37 °C for various time intervals ranging from 1 h to 24 h. The unbound malathion concentration was determined by the LC-MS method. The results showed that malathion was bound to FFP at a concentration of 200.8 mg L -1 , with a t 1/2 of 2.1 h.
Figure 1 BuChE and AChE activity ±SD, with the malathion concentration ±SD in blood
The clinical recovery was gradual. Mechanical ventilation was no longer necessary from day four, and only small daily doses of atropine were needed. The total atropine dose was 735 mg, and pralidoxime was used for four days. The patient's condition improved steadily and he was discharged from the hospital on day seven.
DISCUSSION
Butyrylcholinesterase functions as a natural bioscavenger that binds OPs stoichiometrically and thus inactivates them. The advantage of the prophylactic use of purified human BuChE was confirmed in various OPs, including soman, sarin, and tabun. A single dose of BuChE was able to maintain therapeutic concentrations for at least four days, protecting humans from an exposure of 2 x LD 50 to 5 x LD 50 (3, 6 ). An experimental study on guinea pigs confi rmed that the nerve agents sarin, soman, cyclosarin, and tabun formed phosphorylated adducts with a tyrosine residue on albumin when incubated with human plasma in vitro. Albumin served as a relatively longlived biological marker not only for nerve agents (7), but also for dichlorvos (8) .
No human trials involving BuChE have been conducted due to the high costs and large quantity needed for the inactivation of OPs. An alternative approach would be to use FFP. In a prospective clinical study, Güven et al. (4) applied FFP with atropine and pralidoxime in 12 patients with OP poisoning, while 22 patients were given atropine and oximes (controls). In the control group, the mortality was 14.3 %, and intermediate syndrome (IMS) was 28.6 %, while neither lethal outcomes nor IMS were registered in the group with FFP. Furthermore, plasmapheresis with FFP was used on a patient with fenitrothion poisoning who developed sepsis. After plasma exchange therapy, ChE levels increased and the patient's clinical condition resulted in a complete recovery (9) .
Contrary to this, the results of an open-labelled pilot randomized trial involving the comparison of FFP, albumin, and saline in sixty patients with acute OP poisoning did not show any favourable effects on the clinical outcomes (5). Despite a signifi cant increase in BuChE levels with FFP, a greater number of IMS cases were observed, and there were no differences in atropine requirement, duration of mechanical ventilation, hospital stay or mortality. Two explanations for the unsuccessful treatment were offered: ageing of OP-ChE and OP-albumin complex dissociation (7).
Fulton (10) attempted to explain the favourable effect of FFP found by Güven et al. (4, 9) through discussing "the secret ingredient" and suggested that aggressive volume resuscitation with BuChE serves as a possible scavenger; however, the author did not comment on the same presumed role of albumin.
Our patient was severely poisoned by malathion, with pronounced muscarinic and nicotinic effects and a marked inhibition of AChE and BuChE. The malathion concentration in the patient's blood was 18.01 mg L -1 , which was reduced rapidly by an administration of FFP. This concentration is close to the malathion blood level of 23.9 mg L -1 found antemortem in a suicidal poisoning (11) . Malathion is a dimethyl-organophosphate with a low toxicity in humans. However, many fatal human ingestions of malathion have been documented in the literature, with the lethal doses estimated to range from 350 mg kg -1 to 1000 mg kg -1 (12) . In addition to atropine, oximes, and supportive measures, FFP was administered during two days. A prompt increase of BuChE activity and volume restitution containing albumin eliminated the poison. This was followed by a clinical recovery, which was ascribed to the benefi cial effects of FFP therapy, primarily induced by supplemented BuChE and albumin.
CONCLUSION
The patient with severe malathion poisoning was successfully treated by atropine, oximes, and FFP. The potentially benefi cial effects of FFP are an increase of BuChE activity, colloid volume replacement, and rapid elimination of OPs. We believe that FFP may have helped in this case and that it could be used as a supplement in acute OP poisonings, especially when oximes are not available. ), eliminacija otrova s promptnom redukcijom koncentracije malationa, uz klinički oporavak, mogu se pripisati povoljnim učincima terapije FFP-om kao adjuvansom. FFP osigurava BuChE, povećani sadržaj albumina i nadoknadu volumena, zbog čega se može koristiti kao alternativni način liječenja akutnih trovanja OP-ima, posebno kada nam nisu dostupni oksimi. 
